-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-GSK Says Efimosfermin Receives FDA Breakthrough Therapy & EMA Prime Designations For MASH

Reuters·04/27/2026 11:42:55

Please log in to view news